| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |